CHUV
Les activités du CHUV
MENU
Centre du sein
Accueil > Recherche > Publications > Publications 2013

Publications 2013


  1. Bonnefoi H, Zaman K, Debled M, Fiche M, Fournier M, Nobahar M, Pierga JY, Koch KM, Bartlett J, Zimmer A, Marreaud S, Bogaerts J, Cameron D.
    An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer.
    Eur J Cancer. 2013 Jan;49(2):281-9. PubMed PMID:22999386.

  2. Brédart A, Kop JL, Griesser AC, Fiszer C, Zaman K, Panes-Ruedin B, Jeanneret W, Delaloye JF, Zimmers S, Berthet V, Dolbeault S.
    Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care.
    Ann Oncol. 2013 Aug;24(8):2151-8. doi: 10.1093/annonc/mdt128. Epub 2013 Apr 7. PubMed PMID:23567145.

  3. Dahmane E, Csajka C, Rudaz S, Boccard J, Zaman K, Decosterd L, Genin E, Duretz B, Bromirski M, Leyvraz S, Testa B, Rochat B.
    Quantitative monitoring of tamoxifen extended to forty metabolites in human plasma using LC-HR-MS: New investigation capabilities for clinical pharmacology.
    ASMS 2013, Minneapolis, Minnesota; submitted.

  4. Jacot W, Fiche M, Zaman K, Wolfer A, Lamy PJ.
    The HER2 amplicon in breast cancer: Topoisomerase II and beyond.
    Biochim Biophys Acta. 2013 Aug;1836(1):146-57. doi: 10.1016/j.bbcan.2013.04.004. Epub 2013 Apr 26. PubMed PMID: 23628726.

  5. Zaman K, Thuerlimann B, Aebi S.
    Optimal sequence of tamoxifen and aromatase inhibitors to prevent bone loss.
    J Clin Oncol. 2013 Sep 20;31(27):3440-1. doi: 10.1200/JCO.2013.50.9737. Epub 2013 Aug 5. PubMed PMID:23918950.

  6. Lehr HA, Rochat C, Schaper C, Nobile A, Shanouda S, Vijgen S, Gauthier A, Obermann E, Leuba S, Schmidt M, C CR, Delaloye JF, Simiantonaki N, Schaefer SC.
    Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomas.
    Mod Pathol. 2013 Mar;26(3):336-42. doi: 10.1038/modpathol.2012.140. Epub 2012 Oct 5. PubMed PMID: 23041831.

  7. Kourda J, Nicoulaz AL, Carel A, Bisig B, Delaloye JF, Fiche M.
    Evolution du rôle de l’examen extemporané des ganglions sentinelles des cancers du sein.
    Présentation sous forme de poster aux 36èmes Assises de Pathologie, Versailles, France, 23-24 mai 2013.

  8. Meystre C, Bourquin C, Despland JN, Stiefel F, de Roten Y.
    Working alliance in communication skills training for oncology clinicians: a controlled trial.
    Patient Educ Couns. 2013 Feb;90(2):233-8. doi: 10.1016/j.pec.2012.10.013. Epub 2012 Nov 14. PubMed PMID: 23158787.

  9. Tsoutsou PG, Jeanneret Sozzi W, Ozsahin M, Delaloye JF, Bourhis J.
    Radiotherapy options after breast-conserving surgery: how can selection of patients be refined ?
    J Clin Oncol. 2013 Dec 20;31(36):4570-1. doi: 10.1200/JCO.2013.52.8299. Epub 2013 Nov 4. PubMed PMID: 24190122.

  10. De Vries AM, de Roten Y, Meystre C, Passchier J, Despland JN, Stiefel F.
    Clinician characteristics, communication, and patient outcome in oncology: a systematic review.
    Psychooncology. 2013 Nov 14. doi: 10.1002/pon.3445. PubMed PMID:24243790.

  11. Ibberson M, Bron S, Guex N, Faes-van't Hull E, Ifticene-Treboux A, Henry L, Lehr HA, Delaloye JF, Coukos G, Xenarios I, Doucey MA.
    TIE-2 and VEGFR kinase activities drive immunosuppressive function of TIE-2-expressing monocytes in human breast tumors.
    Clin Cancer Res. 2013 Jul 1;19(13):3439-49. doi: 10.1158/1078-0432.CCR-12-3181. Epub 2013 May 6. PubMed PMID:23649001.

  12. Tanos T, Sflomos G, Echeverria PC, Ayyanan A, Gutierrez M, Delaloye JF, Raffoul W, Fiche M, Dougall W, Schneider P, Yalcin-Ozuysal O, Brisken C.
    Progesterone/RANKL is a major regulatory axis in the human breast.
    Sci Transl Med. 2013 Apr 24;5(182):182ra55. doi: 10.1126/scitranslmed.3005654. PubMed PMID:23616122.

  13. R.Odermatt, A.Wolfer, K. Zaman.
    Endocrine therapy in breast cancer: efficacy and adverse events.
    Rev Med Suisse. 2013 May 22;9(387):1090-4. PubMed PMID:23757917.

  14. Tsoutsou PG, Jeanneret Sozzi W, Matzinger O, Ozsahin M.
    Nomograms predicting locoregional recurrence in the subtype era of breast cancer.
    J Clin Oncol. 2013 Feb 10;31(5):647-8. doi: 10.1200/JCO.2012.46.8587. Epub 2012 Dec 26. PubMed PMID: 23269999.